IMUGENE CHART. TA only, page-8141

Morning All

I will not put Mirren on ignore; her posts are always reasoned and reasonable. She is a holder and has a right to be heard (unlike shameless non-holders who join forums in order to cause havoc or to gloat over others' misfortune).

That said, I do think Mirren misinterpreted Zior's reference to $2.70. To paraphrase, he did not predict $2.70, but did say that would be the price if a past pattern repeated. He then went on to say he didn't predict it would, but that $2.70 was attainable given further results.

And you know what: It's impossible to argue against that conclusion. We have now touched 60 cents, or $3.5 billion, on thin but good - great? - results. Another $2.10 appreciation would result in a market cap of around $17 billion, which in the grand scheme of things is not outlandish.

I hadn't intended to buy into this argument, but Taureanbull's excellent post this morning prompted me to do so. He succinctly outlines the inherent value in just three of our current products in trial, and when you consider the points he makes, a very large valuation for Imugene seems possible in the short-to-medium term.

I've sold five per cent of my holding in recent months simply as a hedge against a poor result - and don't worry, they happen, sometimes unexpectedly. It is a rare stock that goes up in a straight line; even IMU has had its dips. Deep in my psyche, though, I fear I am going to regret not making every post a winner here. Imugene and its seemingly wonder drugs have done nothing wrong thus far.

OOO